S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Greek authorities rescue 91 migrants from river islet on border with Turkey
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
Stock market today: Asian stocks follow Wall St up after strong US jobs report
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Greek authorities rescue 91 migrants from river islet on border with Turkey
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
Stock market today: Asian stocks follow Wall St up after strong US jobs report
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Greek authorities rescue 91 migrants from river islet on border with Turkey
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
Stock market today: Asian stocks follow Wall St up after strong US jobs report
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Greek authorities rescue 91 migrants from river islet on border with Turkey
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
Stock market today: Asian stocks follow Wall St up after strong US jobs report
NASDAQ:LMAT

LeMaitre Vascular (LMAT) Stock Forecast, Price & News

$64.91
+0.89 (+1.39%)
(As of 06/2/2023 08:48 PM ET)
Compare
Today's Range
$63.38
$65.35
50-Day Range
$50.38
$67.58
52-Week Range
$40.82
$68.06
Volume
132,400 shs
Average Volume
96,650 shs
Market Capitalization
$1.44 billion
P/E Ratio
69.80
Dividend Yield
0.86%
Price Target
$62.00

LeMaitre Vascular MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
4.5% Downside
$62.00 Price Target
Short Interest
Healthy
2.74% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
1.45mentions of LeMaitre Vascular in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$9.32 M Sold Last Quarter
Proj. Earnings Growth
20.83%
From $1.20 to $1.45 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.69 out of 5 stars

Medical Sector

64th out of 980 stocks

Surgical & Medical Instruments Industry

6th out of 97 stocks


LMAT stock logo

About LeMaitre Vascular (NASDAQ:LMAT) Stock

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Receive LMAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LeMaitre Vascular and its competitors with MarketBeat's FREE daily newsletter.

LMAT Stock News Headlines

LeMaitre (LMAT) Upgraded to Strong Buy: Here's Why
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
Lake Street Keeps Their Buy Rating on Lemaitre Vascular (LMAT)
Why Shares of LeMaitre Vascular Are Up Wednesday
Q1 2023 LeMaitre Vascular Inc Earnings Call
LeMaitre Q1 2023 Financial Results
See More Headlines

LMAT Price History

LMAT Company Calendar

Ex-Dividend for 3/23 Dividend
3/08/2023
Dividend Payable
3/23/2023
Last Earnings
5/02/2023
Ex-Dividend for 6/1 Dividend
5/16/2023
Dividend Payable
6/01/2023
Today
6/04/2023
Next Earnings (Estimated)
7/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LMAT
Employees
450
Year Founded
1983

Price Target and Rating

Average Stock Price Forecast
$62.00
High Stock Price Forecast
$62.00
Low Stock Price Forecast
$62.00
Forecasted Upside/Downside
-4.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$20.64 million
Pretax Margin
16.26%

Debt

Sales & Book Value

Annual Sales
$161.65 million
Cash Flow
$1.50 per share
Book Value
$12.37 per share

Miscellaneous

Free Float
19,410,000
Market Cap
$1.44 billion
Optionable
Optionable
Beta
0.98

Social Links


Key Executives

  • George W. LeMaitreGeorge W. LeMaitre
    Chairman & Chief Executive Officer
  • David B. RobertsDavid B. Roberts
    President & Director
  • Trent G. KamkeTrent G. Kamke
    Senior Vice President-Operations
  • Joseph P. Pellegrino
    Chief Financial Officer, Secretary & Director
  • Jonathan W. Ngau
    Vice President-Information Technology













LMAT Stock - Frequently Asked Questions

Should I buy or sell LeMaitre Vascular stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LeMaitre Vascular in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" LMAT shares.
View LMAT analyst ratings
or view top-rated stocks.

What is LeMaitre Vascular's stock price forecast for 2023?

2 brokers have issued twelve-month target prices for LeMaitre Vascular's shares. Their LMAT share price forecasts range from $62.00 to $62.00. On average, they anticipate the company's stock price to reach $62.00 in the next twelve months. This suggests that the stock has a possible downside of 4.5%.
View analysts price targets for LMAT
or view top-rated stocks among Wall Street analysts.

How have LMAT shares performed in 2023?

LeMaitre Vascular's stock was trading at $46.02 at the start of the year. Since then, LMAT shares have increased by 41.0% and is now trading at $64.91.
View the best growth stocks for 2023 here
.

When is LeMaitre Vascular's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023.
View our LMAT earnings forecast
.

How were LeMaitre Vascular's earnings last quarter?

LeMaitre Vascular, Inc. (NASDAQ:LMAT) released its quarterly earnings data on Tuesday, May, 2nd. The medical instruments supplier reported $0.27 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.25 by $0.02. The medical instruments supplier had revenue of $47.08 million for the quarter, compared to analyst estimates of $43.54 million. LeMaitre Vascular had a net margin of 12.20% and a trailing twelve-month return on equity of 8.86%. The firm's revenue was up 19.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.27 earnings per share.

How often does LeMaitre Vascular pay dividends? What is the dividend yield for LeMaitre Vascular?

LeMaitre Vascular announced a quarterly dividend on Monday, April 24th. Stockholders of record on Wednesday, May 17th will be given a dividend of $0.14 per share on Thursday, June 1st. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.86%. The ex-dividend date of this dividend is Tuesday, May 16th.
Read our dividend analysis for LMAT
.

Is LeMaitre Vascular a good dividend stock?

LeMaitre Vascular (NASDAQ:LMAT) pays an annual dividend of $0.56 per share and currently has a dividend yield of 0.86%. The company has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 60.22%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, LMAT will have a dividend payout ratio of 38.62% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for LMAT.

What guidance has LeMaitre Vascular issued on next quarter's earnings?

LeMaitre Vascular updated its second quarter 2023 earnings guidance on Wednesday, May, 3rd. The company provided EPS guidance of $0.30-$0.35 for the period, compared to the consensus EPS estimate of $0.31. The company issued revenue guidance of $47.10 million-$49.50 million, compared to the consensus revenue estimate of $44.94 million.

What is George W. LeMaitre's approval rating as LeMaitre Vascular's CEO?

13 employees have rated LeMaitre Vascular Chief Executive Officer George W. LeMaitre on Glassdoor.com. George W. LeMaitre has an approval rating of 33% among the company's employees. This puts George W. LeMaitre in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of LeMaitre Vascular own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LeMaitre Vascular investors own include AbbVie (ABBV), Sociedad Química y Minera de Chile (SQM), Gilead Sciences (GILD), Aurora Cannabis (ACB), Aurora Cannabis (ACBFF), NVIDIA (NVDA), Adobe (ADBE), Boeing (BA) and Salesforce (CRM).

What is LeMaitre Vascular's stock symbol?

LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."

Who are LeMaitre Vascular's major shareholders?

LeMaitre Vascular's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (14.54%), Conestoga Capital Advisors LLC (8.37%), Copeland Capital Management LLC (6.18%), Ranger Investment Management L.P. (4.47%), State Street Corp (3.38%) and Dimensional Fund Advisors LP (3.00%). Insiders that own company stock include David B Roberts, George W Lemaitre, George W Lemaitre, John A Roush, Joseph P Pellegrino Jr, Lawrence J Jasinski and Trent G Kamke.
View institutional ownership trends
.

How do I buy shares of LeMaitre Vascular?

Shares of LMAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LeMaitre Vascular's stock price today?

One share of LMAT stock can currently be purchased for approximately $64.91.

How much money does LeMaitre Vascular make?

LeMaitre Vascular (NASDAQ:LMAT) has a market capitalization of $1.44 billion and generates $161.65 million in revenue each year. The medical instruments supplier earns $20.64 million in net income (profit) each year or $0.93 on an earnings per share basis.

How many employees does LeMaitre Vascular have?

The company employs 450 workers across the globe.

Does LeMaitre Vascular have any subsidiaries?
The following companies are subsidiares of LeMaitre Vascular: Artegraft, Bio Nova Holdings Pty Ltd, Bio Nova International Pty Ltd, Biomateriali, CardioCel, Clinical Instruments, Credent, Endomed, Ideas for Medicine, Inavein, LeMaitre Acquisition LLC, LeMaitre Cardial SAS, LeMaitre Medical Technology (Shanghai) Co., LeMaitre Vascular, LeMaitre Vascular AS, LeMaitre Vascular GK, LeMaitre Vascular GmbH, LeMaitre Vascular Pty Ltd, LeMaitre Vascular S.r.l., LeMaitre Vascular SAS, LeMaitre Vascular Singapore Pte Ltd, LeMaitre Vascular Spain, LeMaitre Vascular Switzerland GmbH, LeMaitre Vascular ULC, LifeSpan, PeriVu, ProCol, Restore Flow Allografts, RestoreFlow, Syntel and Python, TRIVEX, Tru-Incise (Eze-Sit) OUS, Tru-Incise (Eze-Sit) US, UnBalloon, VCS Clip, VascuCel, Vascular Architects, Vascular Innovations, Vascutech Acquisition LLC, Vermed, Whittaker Screen Printing, XenoSure, and Xenotis Pty Ltd.
Read More
How can I contact LeMaitre Vascular?

LeMaitre Vascular's mailing address is 63 SECOND AVENUE, BURLINGTON MA, 01803. The official website for the company is www.lemaitre.com. The medical instruments supplier can be reached via phone at (781) 221-2266 or via fax at 781-425-5049.

This page (NASDAQ:LMAT) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -